Weighted Average Number of Shares Outstanding, Basic of CytoDyn Inc. from 31 May 2020 to 30 Nov 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
CytoDyn Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 May 2020 to 30 Nov 2025.
  • CytoDyn Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Nov 2025 was 1,261,016,000, a 3.2% increase year-over-year.
  • CytoDyn Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 1,205,755,000, a 24% increase from 2023.
  • CytoDyn Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 969,509,000, a 16% increase from 2022.
  • CytoDyn Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 836,528,000, a 24% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

CytoDyn Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 1,261,016,000 +39,611,000 +3.2% 01 Sep 2025 30 Nov 2025 10-Q 09 Jan 2026 2026 Q2
Q3 2025 1,252,551,000 +117,508,000 +10% 01 Jun 2025 31 Aug 2025 10-Q 10 Oct 2025 2026 Q1
Q2 2025 1,205,755,000 +236,246,000 +24% 01 Mar 2025 31 May 2025 10-K 25 Jul 2025 2025 FY
Q1 2025 1,228,259,000 +246,050,000 +25% 01 Dec 2024 28 Feb 2025 10-Q 14 Apr 2025 2025 Q3
Q4 2024 1,221,405,000 +262,417,000 +27% 01 Sep 2024 30 Nov 2024 10-Q 09 Jan 2026 2026 Q2
Q3 2024 1,135,043,000 +211,456,000 +23% 01 Jun 2024 31 Aug 2024 10-Q 10 Oct 2025 2026 Q1
Q2 2024 969,509,000 +132,981,000 +16% 01 Mar 2024 31 May 2024 10-K 25 Jul 2025 2025 FY
Q1 2024 982,209,000 +149,994,000 +18% 01 Dec 2023 29 Feb 2024 10-Q 14 Apr 2025 2025 Q3
Q4 2023 958,988,000 +145,615,000 +18% 01 Sep 2023 30 Nov 2023 10-Q 14 Jan 2025 2025 Q2
Q3 2023 923,587,000 +135,731,000 +17% 01 Jun 2023 31 Aug 2023 10-Q 15 Oct 2024 2025 Q1
Q2 2023 836,528,000 +159,628,000 +24% 01 Mar 2023 31 May 2023 10-K 15 Aug 2024 2024 FY
Q1 2023 832,215,000 +136,601,000 +20% 01 Dec 2022 28 Feb 2023 10-Q 15 Apr 2024 2024 Q3
Q4 2022 813,373,000 +150,773,000 +23% 01 Sep 2022 30 Nov 2022 10-Q 16 Jan 2024 2024 Q2
Q3 2022 787,856,000 +155,259,000 +25% 01 Jun 2022 31 Aug 2022 10-Q 23 Oct 2023 2024 Q1
Q2 2022 676,900,000 01 Mar 2022 31 May 2022 10-K 14 Sep 2023 2023 FY
Q1 2022 695,614,000 +695,036,146 01 Dec 2021 28 Feb 2022 10-Q 10 Apr 2023 2023 Q3
Q4 2021 662,600,000 01 Sep 2021 30 Nov 2021 10-Q 09 Jan 2023 2023 Q2
Q3 2021 632,597,000 01 Jun 2021 31 Aug 2021 10-Q/A 13 Oct 2022 2023 Q1
Q1 2021 577,854* 01 Dec 2020 28 Feb 2021 10-Q 11 Apr 2022 2021 Q3

CytoDyn Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 1,205,755,000 +236,246,000 +24% 01 Jun 2024 31 May 2025 10-K 25 Jul 2025 2025 FY
2023 969,509,000 +132,981,000 +16% 01 Jun 2023 31 May 2024 10-K 25 Jul 2025 2025 FY
2022 836,528,000 +159,628,000 +24% 01 Jun 2022 31 May 2023 10-K 15 Aug 2024 2024 FY
2021 676,900,000 +89,310,000 +15% 01 Jun 2021 31 May 2022 10-K 14 Sep 2023 2023 FY
2020 587,590,000 +166,512,000 +40% 01 Jun 2020 31 May 2021 10-K 15 Aug 2022 2022 FY
2019 421,078,000 01 Jun 2019 31 May 2020 10-K 15 Aug 2022 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.